Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 14,460
+80 (0.56%)
At close: Apr 16, 2025, 3:30 PM KST
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 178.00 billion as of April 17, 2025. Its market cap has increased by 64.56% in one year.
Market Cap
178.00B
Enterprise Value
213.14B
Revenue
5.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,460.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 178.00B, a decrease of -50.63%. That is a compound annual growth rate of -16.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 175.12B | -3.57% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.81T |
| Celltrion | 34.26T |
| ALTEOGEN | 19.53T |
| Yuhan | 8,492.29B |
| SK Biopharmaceuticals | 8,034.94B |
| HLB Co., Ltd. | 7,356.32B |
| LigaChem Biosciences | 3,795.10B |
| PharmaResearch | 3,766.25B |